Biofil Chemicals, a company in the Pharmaceuticals industry, reported revenue of ₹1.67 crore and net profit of ₹0.12 crore for the September 2026 quarter.
Biofil Chemicals (NSE: BIOFILCHEM) closed at ₹29.37 on 20 Nov 2026, down 24.7% over the past year. Its market capitalisation is ₹48 crore and it trades at 91.9 times earnings.
Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd deals in Pharmaceuticals and Chemicals products.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.